|
1
|
Niemetz R and Gross GG: Enzymology of
gallotannin and ellagitannin biosynthesis. Phytochemistry.
66:2001–2011. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shahrzad S, Aoyagi K, Winter A, Koyama A
and Bitsch I: Pharmacokinetics of gallic acid and its relative
bioavailability from tea in healthy humans. J Nutr. 131:1207–1210.
2001.PubMed/NCBI
|
|
3
|
Kang MS, Oh JS, Kang IC, Hong SJ and Choi
CH: Inhibitory effect of methyl gallate and gallic acid on oral
bacteria. J Microbiol. 46:744–750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kratz JM, Andrighetti-Frohner CR, Leal PC,
Nunes RJ, Yunes RA, Trybala E, Bergstrom T, Barardi CR and Simoes
CM: Evaluation of anti-HSV-2 activity of gallic acid and pentyl
gallate. Biol Pharm Bull. 31:903–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim SH, Jun CD, Suk K, Choi BJ, Lim H,
Park S, Lee SH, Shin HY, Kim DK and Shin TY: Gallic acid inhibits
histamine release and pro-inflammatory cytokine production in mast
cells. Toxicol Sci. 91:123–131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inoue M, Sakaguchi N, Isuzugawa K, Tani H
and Ogihara Y: Role of reactive oxygen species in gallic
acid-induced apoptosis. Biol Pharm Bull. 23:1153–1157. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaur M, Velmurugan B, Rajamanickam S,
Agarwal R and Agarwal C: Gallic acid, an active constituent of
grape seed extract, exhibits anti-proliferative, pro-apoptotic and
anti-tumorigenic effects against prostate carcinoma xenograft
growth in nude mice. Pharm Res. 26:2133–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Veluri R, Singh RP, Liu Z, Thompson JA,
Agarwal R and Agarwal C: Fractionation of grape seed extract and
identification of gallic acid as one of the major active
constituents causing growth inhibition and apoptotic death of DU145
human prostate carcinoma cells. Carcinogenesis. 27:1445–1453. 2006.
View Article : Google Scholar
|
|
9
|
Kawada M, Ohno Y, Ri Y, Ikoma T, Yuugetu
H, Asai T, Watanabe M, Yasuda N, Akao S, Takemura G, et al:
Anti-tumor effect of gallic acid on LL-2 lung cancer cells
transplanted in mice. Anticancer Drugs. 12:847–852. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohno Y, Fukuda K, Takemura G, Toyota M,
Watanabe M, Yasuda N, Xinbin Q, Maruyama R, Akao S, Gotou K,
Fujiwara T and Fujiwara H: Induction of apoptosis by gallic acid in
lung cancer cells. Anticancer Drugs. 10:845–851. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Faried A, Kurnia D, Faried LS, Usman N,
Miyazaki T, Kato H and Kuwano H: Anticancer effects of gallic acid
isolated from Indonesian herbal medicine, Phaleria
macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J
Oncol. 30:605–613. 2007.PubMed/NCBI
|
|
12
|
Chen HM, Wu YC, Chia YC, Chang FR, Hsu HK,
Hsieh YC, Chen CC and Yuan SS: Gallic acid, a major component of
Toona sinensis leaf extracts, contains a ROS-mediated
anti-cancer activity in human prostate cancer cells. Cancer Lett.
286:161–171. 2009.PubMed/NCBI
|
|
13
|
Strlic M, Radovic T, Kolar J and Pihlar B:
Anti- and prooxidative properties of gallic acid in fenton-type
systems. J Agric Food Chem. 50:6313–6317. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sakagami H and Satoh K: Prooxidant action
of two antioxidants: ascorbic acid and gallic acid. Anticancer Res.
17:221–224. 1997.PubMed/NCBI
|
|
15
|
Zelko IN, Mariani TJ and Folz RJ:
Superoxide dismutase multigene family: a comparison of the CuZn-SOD
(SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures,
evolution, and expression. Free Radic Biol Med. 33:337–349. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilcox CS: Reactive oxygen species: roles
in blood pressure and kidney function. Curr Hypertens Rep.
4:160–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Genestra M: Oxyl radicals, redox-sensitive
signalling cascades and antioxidants. Cell Signal. 19:1807–1819.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blenis J: Signal transduction via the MAP
kinases: proceed at your own RSK. Proc Natl Acad Sci USA.
90:5889–5892. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kusuhara M, Takahashi E, Peterson TE, Abe
J, Ishida M, Han J, Ulevitch R and Berk BC: p38 Kinase is a
negative regulator of angiotensin II signal transduction in
vascular smooth muscle cells: effects on
Na+/H+ exchange and ERK1/2. Circ Res.
83:824–831. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsin YH, Chen CF, Huang S, Shih TS, Lai PS
and Chueh PJ: The apoptotic effect of nanosilver is mediated by a
ROS- and JNK-dependent mechanism involving the mitochondrial
pathway in NIH3T3 cells. Toxicol Lett. 179:130–139. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mao X, Yu CR, Li WH and Li WX: Induction
of apoptosis by shikonin through a ROS/JNK-mediated process in
Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell
Res. 18:879–888. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guyton KZ, Liu Y, Gorospe M, Xu Q and
Holbrook NJ: Activation of mitogen-activated protein kinase by
H2O2. Role in cell survival following oxidant
injury. J Biol Chem. 271:4138–4142. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Henson ES and Gibson SB: Surviving cell
death through epidermal growth factor (EGF) signal transduction
pathways: implications for cancer therapy. Cell Signal.
18:2089–2097. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Petty RD, Nicolson MC, Kerr KM,
Collie-Duguid E and Murray GI: Gene expression profiling in
non-small cell lung cancer: from molecular mechanisms to clinical
application. Clin Cancer Res. 10:3237–3248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
You BR, Kim SZ, Kim SH and Park WH: Gallic
acid-induced lung cancer cell death is accompanied by ROS increase
and glutathione depletion. Mol Cell Biochem. 357:295–303. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
You BR and Park WH: Gallic acid-induced
lung cancer cell death is related to glutathione depletion as well
as reactive oxygen species increase. Toxicol In Vitro.
24:1356–1362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han YH, Moon HJ, You BR, Yang YM, Kim SZ,
Kim SH and Park WH: The MEK inhibitor PD98059 attenuates growth
inhibition and death in gallic acid-treated Calu-6 lung cancer
cells by preventing glutathione depletion. Mol Med Rep. 3:519–524.
2010.PubMed/NCBI
|
|
28
|
Han YH, Moon HJ, You BR, Kim SZ, Kim SH
and Park WH: JNK and p38 inhibitors increase and decrease
apoptosis, respectively, in pyrogallol-treated calf pulmonary
arterial endothelial cells. Int J Mol Med. 24:717–722.
2009.PubMed/NCBI
|
|
29
|
Han YH, Moon HJ, You BR, Kim SZ, Kim SH
and Park WH: Effects of carbonyl cyanide p-(trifluoromethoxy)
phenylhydrazone on the growth inhibition in human pulmonary
adenocarcinoma Calu-6 cells. Toxicology. 265:101–107. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han YH, Kim SZ, Kim SH and Park WH:
Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the
changes of intracellular GSH levels rather than ROS levels. Lung
Cancer. 59:301–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han YH, Moon HJ, You BR and Park WH: The
effect of MG132, a proteasome inhibitor on HeLa cells in relation
to cell growth, reactive oxygen species and GSH. Oncol Rep.
22:215–221. 2009.PubMed/NCBI
|
|
32
|
Han YH, Kim SH, Kim SZ and Park WH:
Carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) as an
O2(*−) generator induces apoptosis via the
depletion of intracellular GSH contents in Calu-6 cells. Lung
Cancer. 63:201–209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han YH, Kim SH, Kim SZ and Park WH:
Caspase inhibitor decreases apoptosis in pyrogallol-treated lung
cancer Calu-6 cells via the prevention of GSH depletion. Int J
Oncol. 33:1099–1105. 2008.PubMed/NCBI
|
|
34
|
Han YH, Kim SZ, Kim SH and Park WH:
Intracellular GSH level is a factor in As4.1 juxtaglomerular cell
death by arsenic trioxide. J Cell Biochem. 104:995–1009. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han YH and Park WH: Propyl gallate
inhibits the growth of HeLa cells via regulating intracellular GSH
level. Food Chem Toxicol. 47:2531–2538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bain J, McLauchlan H, Elliott M and Cohen
P: The specificities of protein kinase inhibitors: an update.
Biochem J. 371:199–204. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park WH: MAPK inhibitors differentially
affect gallic acid-induced human pulmonary fibroblast cell growth
inhibition. Mol Med Rep. 4:193–204. 2011.PubMed/NCBI
|
|
38
|
Kang MK, Kang NJ, Jang YJ, Lee KW and Lee
HJ: Gallic acid induces neuronal cell death through activation of
c-Jun N-terminal kinase and downregulation of Bcl-2. Ann NY Acad
Sci. 1171:514–520. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Croons V, Martinet W, Herman AG,
Timmermans JP and De Meyer GR: The protein synthesis inhibitor
anisomycin induces macrophage apoptosis in rabbit atherosclerotic
plaques through p38 mitogen-activated protein kinase. J Pharmacol
Exp Ther. 329:856–864. 2009. View Article : Google Scholar
|
|
40
|
You BR and Park WH: The effects of
mitogen-activated protein kinase inhibitors or small interfering
RNAs on gallic acid-induced HeLa cell death in relation to reactive
oxygen species and glutathione. J Agric Food Chem. 59:763–771.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Marshall NJ, Goodwin CJ and Holt SJ: A
critical assessment of the use of microculture tetrazolium assays
to measure cell growth and function. Growth Regul. 5:69–84.
1995.PubMed/NCBI
|
|
42
|
Serrano A, Palacios C, Roy G, Cespon C,
Villar ML, Nocito M and Gonzalez-Porque P: Derivatives of gallic
acid induce apoptosis in tumoral cell lines and inhibit lymphocyte
proliferation. Arch Biochem Biophys. 350:49–54. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Han YH, Kim SZ, Kim SH and Park WH:
Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by
diethyldithiocarbamate or buthionine sulfoximine. Int J Oncol.
33:205–213. 2008.PubMed/NCBI
|
|
44
|
Han YH, Kim SZ, Kim SH and Park WH:
Suppression of arsenic trioxide-induced apoptosis in HeLa cells by
N-acetylcysteine. Mol Cells. 26:18–25. 2008.PubMed/NCBI
|
|
45
|
Estrela JM, Ortega A and Obrador E:
Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci.
43:143–181. 2006. View Article : Google Scholar
|
|
46
|
Han YH, Moon HJ, You BR, Kim SZ, Kim SH
and Park WH: The effects of buthionine sulfoximine,
diethyldithiocarbamate or 3-amino-1,2,4-triazole on propyl
gallate-treated HeLa cells in relation to cell growth, reactive
oxygen species and glutathione. Int J Mol Med. 24:261–268.
2009.
|
